In 2024, the exchanges operated by SIX, SIX Swiss Exchange and BME Exchange, recorded a combined turnover of CHF 1,582,659 million, an increase of 5.6% over the previous year, and welcomed the two biggest IPOs in Europe, with Galderma and Puig. In the first two months of 2025, the combined turnover has progressed by 18.9%.

Focus on Pragmatic Innovation

In a new interview, Simon McQuoid-Mason, Head Equity Product & Quant Research at Exchanges, shares his impression of the positive start to the year in terms of trading volumes and listings, since both SIX Swiss Exchange and BME Exchange already celebrated two successful IPOs on their main markets, with BioVersys and HBX Group respectively.

In the interview, Simon also outlines what he sees as the key challenges for the industry this year. While this includes liquidity fragmentation, he emphasizes that SIX has always been in favour of competition and choice for market participants, focusing on pragmatic innovation and developing products and services.

Watch the full clip to discover in more detail how SIX addresses liquidity fragmentation for the benefit of trading participants.

The interview was filmed by The Trade during the EMEA Trading Conference 2025, where SIX Swiss Exchange and BME Exchange were present with a booth.